Labetalol Suppliers & Bulk Manufacturers
Available Forms: Tablet / Injection
Available Strengths: 100 mg, 200 mg, 5mg/ml
Reference Brands: Trandate (USA/India), Normodyne (LATAM)
Category:
Hypertension
Labetalol injection is used to treat severe high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly.
Labetalol is available in Tablet / Injection
and strengths such as 100 mg, 200 mg, 5mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Labetalol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Labetalol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Labetalol is a combined alpha- and beta-adrenergic blocker widely used for the management of hypertension, particularly in acute and chronic cardiovascular conditions. By reducing heart rate and cardiac output (beta-blockade) and relaxing blood vessels (alpha-blockade), labetalol effectively lowers blood pressure while offering cardiovascular protection. It is FDA-approved for treating arterial hypertension, ranging from stable chronic cases to acute hypertensive crises, making it a versatile option in both inpatient and outpatient settings.
In clinical practice, labetalol is also commonly used off-label for acute hypertension during pregnancy, as well as hypertension associated with acute ischemic stroke and intracranial hemorrhage, including subarachnoid hemorrhage. Its dual mechanism of action provides rapid blood pressure control, making it a preferred choice in emergencies.
Labetalol therapy requires careful patient selection, monitoring, and awareness of contraindications, as its negative inotropic and chronotropic effects can impact cardiac function. Overall, labetalol plays a critical role in cardiovascular management, offering both acute intervention in hypertensive crises and long-term control in chronic cardiovascular disease, thereby contributing to reduced morbidity and mortality in eligible patient populations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing